Circulating Immune Cells in Patients With Surgically Resected Nonfunctional Pancreatic Neuroendocrine Tumors

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-3-s2-p140
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Prognosis of Sporadic Resected Small (≤2 Cm) Nonfunctional Pancreatic Neuroendocrine Tumors – A Multi-Institutional Study

HPB
HepatologyGastroenterology
2018English

A Single Institutionʼs 26-Year Experience With Nonfunctional Pancreatic Neuroendocrine Tumors

Annals of Surgery
Surgery
2014English

Pancreatic Neuroendocrine Tumors

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2017English

Promising Developments for Pancreatic Neuroendocrine Tumors

Cancer Discovery
Oncology
2011English

Sunitinib in Pancreatic Neuroendocrine Tumors. Clinical Case

Medical Council
2019English

Circulating Markers in Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs)

2012English

Risk Factors for Pancreatic Neuroendocrine Tumors

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2014English

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors

Cancers
Cancer ResearchOncology
2010English

Prognostic Significance of XB130 Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma

World Journal of Surgical Oncology
SurgeryOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy